Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 134
Selected: 0
NCT IDTitle
NCT04632173Head and Neck cancERs International cOviD-19 collabOraTion
NCT04087473Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
NCT01135056Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)
NCT01228045A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT04451603LiverMultiScan Analysis of MRI Scans in HCC
NCT03091491Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer
NCT00690872Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
NCT03093831Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
NCT02559336Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General Hospital
NCT05377034Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
NCT03711422Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
NCT01341834Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
NCT07133269Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
NCT04965259Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
NCT00486213Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
NCT00702182Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer
NCT00003576Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
NCT02548039To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients.
NCT07116161Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore
NCT00687648Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT00997906Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC
NCT05581550Somatostatin Receptor Imaging in NPC, EBV Related Cancers
NCT04230330Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
NCT05724264SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)
NCT05211882ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore
NCT03429972Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
NCT04448522Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
NCT04242251Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study
NCT03100006Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
NCT04986748Using QPOP to Predict Treatment for Sarcomas and Melanomas
NCT05148572Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma
NCT02408497Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy
NCT03984578Window of Opportunity Study in Colorectal Cancer
NCT00801411Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
NCT05929885Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
NCT05516628Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
NCT03422432Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
NCT05355558A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer
NCT00263484Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
NCT06244953Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
NCT03097939Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
NCT06418412A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
NCT00702481Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
NCT03267641Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma
NCT02944708Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma
NCT04961489Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
NCT04946968Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers
NCT00467194Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT00565708Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
NCT02801734Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer